Abstract: Provided herein are compositions to treat Clostridioides difficile (C. difficile), Mycobacterium tuberculosis (M. tuberculosis) and Enterococcus faecalis (E. faecalis). These compositions are related to the known compounds (+)-Puupehenone and (+)-ent-Chromazonarol, which are both naturally occurring products. The new compositions were shown to potently inhibit both growth and toxin production of C. difficile as well as inhibit the growth and survival of both replicating and dormant M. tuberculosis. In the United States the C. difficile burden is approximately 453,000 hospital cases and 29,000 deaths annually. Globally, about 10 million people fall ill from tuberculosis and 1.4 million died from the disease. In addition, the known compound (+)-ent-Chromazonarol (10) was found for the first time to strongly inhibit the growth of E. faecalis. E. faecalis has grown drug resistant to vancomycin.

Abstract: A merchandise package includes a back panel and a front panel coupled to the back panel. At least one of the back panel and front panel defines a first channel for retaining a plurality of items. A window defined in the front panel communicates with the first channel. An alternative merchandise package includes a back panel, a front panel mounted to the back panel and a partition member. The partition member extends from the front panel to define a plurality of channels between the front and back panels for retaining a plurality of items. A window defined in the front panel communicates with at least one of the channels. The merchandise package may be used to contain a quantity of items, such as battery packages, for sale as a collective unit. Subsequently, the window may be exposed, and the individual items or packages contained therein may be sold individually. Hence, the merchandise package functions as both a bulk package and a retail display.